MITO - Stealth BioTherapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Stealth BioTherapeutics Corp's activity chart (see below) currently has 14 price targets and 15 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 18.18% of the time, taking 35.45 days on average.

Most recent stock forecast was given by from HC WAINWRIGHT on 23-May-2022. First documented stock forecast 11-Mar-2019.

Best performing analysts who are covering MITO - Stealth BioTherapeutics Corp:

Matthew Luchini Christopher Marai Yi Chen Maury Raycroft Joshua Schimmer Charles Duncan

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-May-2022

$5

4 years 5 months 29 days ago
(23-May-2022)

0/2 (0%)

$3.68 (278.79%)

Hold Since 12-Mar-2019

$1.75

$16

6 years 3 months 11 days ago
(10-Aug-2020)

1/2 (50%)

$-0.2 (-10.26%)

8

Hold Since 02-Apr-2020

$2

6 years 3 months 15 days ago
(06-Aug-2020)

1/2 (50%)

$0.05 (2.56%)

187

Buy Since 12-Mar-2019

$28

6 years 7 months 18 days ago
(03-Apr-2020)

0/3 (0%)

$21.76 (348.72%)

Buy Since 27-Sep-2019

$10

$10

6 years 8 months 18 days ago
(03-Mar-2020)

0/3 (0%)

$6.93 (225.73%)

Show more analysts

Please expand the browser size to see the chart

What is MITO (Stealth BioTherapeutics Corp) average time for price targets to be met?

On average it took 35 days for the stock forecasts to be reached, with an average price target met ratio of 18.18%.

Which analyst most recently updated their price target on MITO (Stealth BioTherapeutics Corp)?

Which analyst has the most public recommendations on MITO (Stealth BioTherapeutics Corp)?

has 0 price targets and 0 ratings on MITO

Which analyst is the currently most bullish on MITO (Stealth BioTherapeutics Corp)?

Charles Duncan with the highest potential upside of $9.68

Which analyst is the currently most reserved on MITO (Stealth BioTherapeutics Corp)?

Christopher Marai with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?